BMS-986020 sodium 869DC801 KI-7 potentiates the cAMP accumulation

KI-7 potentiates the cAMP accumulation induced by the non-selective A2B adenosine receptor agonist NECA (EC50=445

Molecular Weight: 4531

and area under the curve (AUC) values of 2606 (ng*hr/mL)

Telbivudine is a synthetic thymidine nucleoside analogue

2S)-1-{[(1S)-5-amino-1-{[(1S)-1-{[(1S)-5-amino-1-{[(1S)-4-carbamimidamido-1-{[(1S)-1-carbamoyl-2-(4-hydroxyphenyl)ethyl]carbamoyl}butyl]carbamoyl}pentyl]carbamoyl}-2-carbamoylethyl]carbamoyl}pentyl]carbamoyl}-2-methylbutyl]carbamoyl}-2-hydroxyethyl]carbamoyl}-3-carbamoylpropyl]carbamoyl}-3-methylbutyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}pentyl]carbamoyl}pentyl]carbamoyl}ethyl]carbamoyl}ethyl]carbamoyl}-2-methylpropyl]carbamoyl}-3-carbamoylpropyl]carbamoyl}pentyl]carbamoyl}-4-carbamimidamidobutyl]carbamoyl}-3-methylbutyl]carbamoyl}-4-carbamimidamidobutyl]carbamoyl}-2-hydroxypropyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-carbamoylethyl]carbamoyl}-3-[(2S

BMS-986020 sodium 869DC801 KI-7 potentiates the cAMP accumulationBMS 986020 sodium is a high affinity lysophosphatidic acid receptor 1 (LPA1) antagonist. BMS 986020 sodium inhibits bile acid and phospholipid transporters with IC50s of 4. 8 M, 6. 2 M, and 7. 5 M for BSEP, MRP4, and MDR3, respectively. BMS 986020 sodium has the potential for the treatment of idiopathic pulmonary fibrosis (IPF). Product information CAS Number: 1380650 53 2 Molecular Weight: 504. 51 Formula: C29H25N2NaO5 Chemical Name: sodium 1 {4' [3